Can hematuria cause leukocytes on urinalysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Blood in the Urine Cause Leukocytes on Urinalysis?

No, hematuria (blood in the urine) does not directly cause leukocytes to appear on urinalysis—these are distinct findings that reflect different underlying processes.

Understanding the Distinction

Hematuria and leukocyturia are separate entities:

  • Hematuria is defined as ≥3 red blood cells per high-power field on microscopic examination and indicates bleeding from anywhere in the urinary tract 1, 2, 3
  • Leukocyturia (white blood cells in urine) most commonly indicates urinary tract infection when accompanied by bacteriuria, or may reflect inflammation, contamination, or non-infectious causes 4
  • These findings can coexist but one does not cause the other 5, 1

When Both Findings Occur Together

The simultaneous presence of hematuria and leukocytes suggests specific clinical scenarios:

  • Urinary tract infection is the most common cause when both pyuria (white blood cells) and bacteriuria are present together with hematuria 5, 3
  • Glomerulonephritis may present with both findings, particularly when accompanied by proteinuria >2+ on dipstick, red cell casts, and dysmorphic RBCs 5, 6
  • Bladder pathology including stones, tumors, or inflammation can produce both hematuria and pyuria 1, 6

Critical Diagnostic Approach

When you encounter both hematuria and leukocytes on urinalysis:

  1. Confirm true hematuria with microscopic examination showing ≥3 RBCs/HPF, not just dipstick positivity (which has only 65-99% specificity) 1, 2

  2. Assess for infection by checking for bacteriuria, nitrites, and clinical symptoms (dysuria, frequency, fever) 1, 3

  3. If infection is confirmed: Treat appropriately and repeat urinalysis 6 weeks after treatment 1, 3

    • If hematuria resolves after treating the UTI in low-risk patients, no additional evaluation is necessary 1
    • If hematuria persists after successful UTI treatment, proceed with full hematuria evaluation 1
  4. If no infection is present: Leukocyturia without significant bacteriuria mandates further diagnostic evaluation to identify the underlying cause 4

Common Pitfall to Avoid

Never assume hematuria is solely from UTI without confirming infection and considering malignancy risk 1. The presence of pyuria does not exclude malignancy and should never delay complete urologic evaluation in patients with risk factors such as age >40 years, smoking history, or gross hematuria 1, 6, 3.

References

Guideline

Evaluation and Management of Hematuria in Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation of Hematuria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Urine diagnosis and leukocyturia].

MMW Fortschritte der Medizin, 2004

Guideline

acr appropriateness criteria<sup>®</sup> hematuria-child.

Journal of the American College of Radiology, 2018

Guideline

Hematuria Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

I have low back pain and my urinalysis shows trace intact hematuria and 30 mg/dL protein with otherwise normal findings; what evaluation and management should I pursue?
What is the recommended evaluation and management for a patient with a urinalysis showing a small amount of blood and trace protein?
What is the appropriate management for a patient with urinalysis revealing 2+ hematuria, 2+ proteinuria, and leukocyturia?
How should an adult with hematuria and a sterile urine culture be evaluated and managed?
How should I manage a patient whose urinalysis shows hematuria, red blood cells, white blood cells, bacteria, hyaline casts, budding yeast, and calcium oxalate crystals?
What is the recommended initiation and titration schedule for quetiapine extended‑release (Seroquel XR) in treating major depressive disorder?
Is it safe for a patient taking about 60 mg of amphetamine‑dextroamphetamine (Adderall) per month to also use low‑dose quetiapine (Seroquel) as a sleep aid?
What liver, muscle, renal, pregnancy, and drug‑interaction safety concerns and monitoring are required when prescribing Nexlizet (ezetimibe 10 mg/rosuvastatin)?
What is the clinical significance and recommended evaluation of an 8 mm calcification in the mid‑pole of the right kidney on imaging?
What low‑density lipoprotein cholesterol (LDL‑C) target should be set for an adult with markedly elevated lipoprotein (a) (≥50 mg/dL) without established atherosclerotic cardiovascular disease, and how does the target change if the patient has ASCVD, familial hypercholesterolemia, diabetes with target organ damage, or another major risk factor?
Do these urinalysis findings—microscopic hematuria, mild proteinuria, low urine pH, specific gravity 1.025, small bilirubin, and no nitrite or leukocyte esterase—indicate nephrolithiasis (kidney stones)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.